| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +26,050 | 100% | $1.92 | +$50,016 |
| Sells | 0 | ||||
| Net | +1 | +26,050 | 100% | +$50,016 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Faheem Hasnain | President & CEO, Director | $22,610,034 | 02 Jan 2026 | ||
| Waage Christian | EVP, Tech Ops and Admin | $3,193,472 | 02 Jan 2026 | ||
| Bryan Giraudo | Coo/Cfo | $3,148,483 | 02 Jan 2026 | ||
| Richard Aranda | Chief Medical Officer | $1,685,634 | 02 Jan 2026 | ||
| Robert Paul Smith JR | Chief Commercial Officer | $1,034,950 | 02 Jan 2026 | ||
| Caryn Peterson | EVP, Regulatory Affairs | $938,785 | 02 Jan 2026 | ||
| Sandra Milligan | Director | $111,456 | +$50,016 | +81% | 19 Aug 2025 |
| Laura Carter | Chief Scientific Officer | $60,088 | 20 Mar 2023 | ||
| John D. Quisel | Director | 25 Jun 2025 | |||
| RENEE D. GALA | Director | 08 Jun 2023 | |||
| Kristina Burow | Director | 08 Jun 2023 | |||
| Joshua H. Bilenker | Director | 09 Jun 2022 | |||
| Russell J. Cox | Director | 25 Jun 2025 | |||
| Thomas O. Daniel | Director | 25 Jun 2025 | |||
| Skye Drynan | Director | 25 Jun 2025 | |||
| Steven D. Nathan | Director | 25 Jun 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|